Prostate cancer treatment with exercise medicine
Abstract
Exercise can reduce the risk of death in men with prostate cancer. Although the effect was demonstrated over 10 years ago, exercise medicine is still not recognised as a critical therapy in cancer management. Nevertheless, the evidence base is building, and an ongoing randomised controlled trial has been designed to assess whether a targeted and highly sophisticated exercise medicine intervention causes a survival advantage in men with metastatic castrate-resistant prostate cancer.
RAS ID
56683
Document Type
Journal Article
Date of Publication
2022
School
School of Medical and Health Sciences / Exercise Medicine Research Institute
Copyright
free_to_read
Publisher
Wiley
Recommended Citation
Newton, R. U., Hart, N. H., Galvao, D. A., Taaffe, D. R., & Saad, F. (2022). Prostate cancer treatment with exercise medicine. DOI: https://doi.org/10.1002/tre.884
Comments
Newton, R. U., Hart, N. H., Galvão, D. A., Taaffe, D. R., & Saad, F. (2022). Prostate cancer treatment with exercise medicine. Trends in Urology & Men's Health, 13(6), 14-19. https://doi.org/10.1002/tre.884